• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMÉRIEUX, SA ETEST MEROPENEM MP 32 WW B30; ETEST® MEROPENEM MP 32 WW B30

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMÉRIEUX, SA ETEST MEROPENEM MP 32 WW B30; ETEST® MEROPENEM MP 32 WW B30 Back to Search Results
Catalog Number 513800
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Event Description
A customer in (b)(6) notified biomérieux of false susceptible meropenem results for enterobacter cloacae complex in association with the etest® meropenem mp 32 ww b30 (ref 513800, lot 1007496370).The isolate was collected from a patient urine specimen.Initial testing with the etest® meropenem mp 32 ww b30 obtained a meropenem mic = 2 mg/l (susceptible).The strain was also tested with the vitek® 2 ast-n248 test kit and the vitek® 2 ast-n387 test kit.Both vitek® 2 tests obtained the same result of mic > 8 mg/l (resistant).Agar diffusion testing was also performed as an alternative method and obtained a resistant result of d = 15 mm (resistant).Polymerase chain reaction (pcr) testing indicated that the strain was a carbapenem-resistant strain.The customer indicated that the false susceptible etest® result was not reported to the physician.There is no indication or report from the laboratory that this event led to any adverse event related to the patient's state of health.A biomérieux internal investigation will be initiated.
 
Manufacturer Narrative
An investigation was initiated in response to a customer complaint of false susceptible meropenem results for enterobacter cloacae complex in association with the etest® meropenem mp 32 ww b30 (ref 513800, lot 1007496370).The isolate was collected from a patient urine specimen.1.Retained samples analysis: retain samples for the customer's lot number 1007496370 were investigated and tested in parallel with a reference lot number 1007900020.Conformance to specifications was verified with the following atcc quality control strains that were also tested to release etest mp32 strips: atcc 25285 bacteroides fragilis, atcc 49619 streptococcus pneumoniae, atcc 49766 haemophilus influenzae, atcc 27853 pseudomonas aeruginosa, atcc 25922 escherichia coli.The etest® mp32 performance of the impacted lot and the reference lot number comply with the specifications.2.Analysis of provided strains: the customer submitted the strain for investigational testing.The received strain was verified to be enterobacter cloacae complex with the vitek® 2 gn id test kit.The strain was tested by the agar dilution (ad) method and broth micro dilution (bmd) method since ad was the method used for the etest mp32 strips development and bmd was the method used for meropenem drugs development in ast-n248 and ast-n387 cards used by the customer.Eucast clinical 2020 breakpoints were applied.Ad: mic = 2 mg/l (susceptible), bmd: mic = 16 mg/l (resistant), etest mp 32: mic = 4 mg/l (intermediate) on both lots.3.Results analysis: the customer's susceptible results were not reproduced internally.Etest mp32 mics are within essential agreement compared to the reference mics (ad) but lead to minor errors or category.The reference mic (ad) is on the breakpoint (mic = 2 mg/l s) so within one doubling dilution, mic interpretation can shift from s to i.This strain is a borderline strain for meropenem.4.Complaint trend analysis: no other complaints were registered for etest mp32 lot number 1007496370.5.Conclusion: the investigation concluded that the customer's lot 1007496370 is performing in accordance with specifications.The customer's susceptible results were not reproduced internally.Etest mp32 mics are within essential agreement compared to the reference mics (ad) but lead to minor errors or category.This strain is a borderline strain for meropenem.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ETEST MEROPENEM MP 32 WW B30
Type of Device
ETEST® MEROPENEM MP 32 WW B30
Manufacturer (Section D)
BIOMÉRIEUX, SA
3 route de port michaud
la balme 39390
FR  39390
MDR Report Key9920460
MDR Text Key225600313
Report Number9615754-2020-00059
Device Sequence Number1
Product Code JWY
Combination Product (y/n)N
PMA/PMN Number
K010363
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 07/22/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/03/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/17/2022
Device Catalogue Number513800
Device Lot Number1007496370
Was Device Available for Evaluation? No
Date Manufacturer Received06/25/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-